Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer"
- PMID: 40152435
- PMCID: PMC12086389
- DOI: 10.1210/clinem/dgaf185
Correction to: "Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer"
Erratum for
-
Cabozantinib Plus Ipilimumab/Nivolumab in Patients With Previously Treated Advanced Differentiated Thyroid Cancer.J Clin Endocrinol Metab. 2025 Feb 18;110(3):830-837. doi: 10.1210/clinem/dgae512. J Clin Endocrinol Metab. 2025. PMID: 39133806 Free PMC article. Clinical Trial.
Publication types
LinkOut - more resources
Full Text Sources
